4. *If in the previous question you for the below listed medicines, please define answered ‘Never’ the reasons for non-availability over the past 24 months: Not licensed in Not procured Budget Don’t know Other* the country in the country limitations [in this table you will see the medicines that were selected as ‘Never’] 5. *Other (please specify the reasons for non-availability over the past 24 months) [in this table you will see the medicines that were selected as ‘Other*’] 6. *If in question 3 you answered for the below listed medicines, please ‘Usually’ or ‘Occasionally’ define the reasons for intermittent non-availability over the past 24 months: Shortages Budget Don’t know Other* limitations [in this table you will see the medicines that were selected as ‘Usually’ or ‘Occasionally’ ] 7. *Other (please specify the reasons for intermittent non-availability over the past 24 months) [in this table you will see the medicines that were selected as ‘Other*’]
4. *If in the previous question you answered ‘Never’ for the below listed medicines, please define the reasons for non-availability over the past 24 months: Not licensed in the country Not procured in the country Budget limitations Don’t know Other* [in this table you will see the medicines that were selected as ‘Never’] 5. *Other (please specify the reasons for non-availability over the past 24 months) [in this table you will see the medicines that were selected as ‘Other*’] 6. *If in question 3 you answered ‘Usually’ or ‘Occasionally’ for the below listed medicines, please define the reasons for intermittent non-availability over the past 24 months: Shortages Budget limitations Don’t know Other* [in this table you will see the medicines that were selected as ‘Usually’ or ‘Occasionally’ ] 7. *Other (please specify the reasons for intermittent non-availability over the past 24 months) [in this table you will see the medicines that were selected as ‘Other*’]
Survey_Part_I_antineoplastic.docx